Your browser doesn't support javascript.
loading
PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.
Jensen, J D; Knoop, A; Laenkholm, A V; Grauslund, M; Jensen, M B; Santoni-Rugiu, E; Andersson, M; Ewertz, M.
Affiliation
  • Jensen JD; Department of Oncology, Odense University Hospital, Odense; Institute of Clinical Research, University of Southern Denmark, Odense. Electronic address: jeanette.dupont.jensen@ouh.regionsyddanmark.dk.
  • Knoop A; Department of Oncology, Odense University Hospital, Odense; Institute of Clinical Research, University of Southern Denmark, Odense.
  • Laenkholm AV; Department of Pathology, Slagelse Hospital, Slagelse.
  • Grauslund M; Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
  • Jensen MB; Danish Breast Cancer Cooperative Group Data Center, Copenhagen.
  • Santoni-Rugiu E; Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
  • Andersson M; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Ewertz M; Department of Oncology, Odense University Hospital, Odense; Institute of Clinical Research, University of Southern Denmark, Odense.
Ann Oncol ; 23(8): 2034-2042, 2012 Aug.
Article in En | MEDLINE | ID: mdl-22172323
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Phosphatidylinositol 3-Kinases / PTEN Phosphohydrolase Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2012 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptor, ErbB-2 / Phosphatidylinositol 3-Kinases / PTEN Phosphohydrolase Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2012 Document type: Article Country of publication: United kingdom